Your Search for 'Japan Pharmaceuticals and Healthcare Report Q1 2011' returned 124 results - Page 1 of 7

• Bayer HealthCare AG Market Share Analysis

  EURO€ 769.00USD$ 1,000.00GBP£ 647.00AUD$ 978.00JPY¥ 98,733.00SEK 6 566,00CHF 943.00CAD$ 1,019.00 GlobalData, Oct 2012 , Pages: 119
  strategies by leveraging on the key data and information provided in the report, which includes but not limited to Bayer HealthCare AG’s market positions. 1 1 1.1 List of Tables 1.2 List of Figures 2 ...

• Global Animal Health Care Market Outlook to 2016 - Growth Opportunity in the Emerging Asia

  EURO€ 673.00USD$ 875.00GBP£ 566.00AUD$ 856.00JPY¥ 86,391.00SEK 5 745,00CHF 825.00CAD$ 892.00 Ken Research Private Limited, Aug 2012 , Pages: 155
  REPORT - The market size of the Global animal health care Industry and its segments such as pharmaceuticals, vaccines, medical feeds, farm and companion animals, 2006-2011 - The market size of the animal ...

• Biotechnology in India - Global Business Strategic Report

  EURO€ 3,496.00USD$ 3,950.00GBP£ 2,330.00AUD$ 5,462.00JPY¥ 473,679.00SEK 31 073,00CHF 5'202.00CAD$ 5,066.00 Global Industry Analysts, Inc, May 2012 , Pages: 396
  I-3 II. AN INDIAN MARKET REPORT 1. OUTLOOK II-1 Recession and Foreign Exchange Rate Decelerate Industry Growth II-1 ...

• BioPharmaceutical Industry in China - An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges

  EURO€ 2,000.00USD$ 2,602.00GBP£ 1,683.00AUD$ 2,545.00JPY¥ 256,897.00SEK 17 084,00CHF 2'452.00CAD$ 2,651.00 Kelly Scientific Publications, Dec 2012 , Pages: 105
  opportunities. This report is supported with 114 tables and 40 figures. The Chinese Pharmaceutical market is currently the third greatest pharma market globally, after the US and Japan, and in 2011 was worth ...

• Saudi Arabia Pharmaceuticals and Healthcare Report Q4 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Oct 2012 , Pages: 104
  Saudi Arabia Pharmaceuticals and Healthcare Report Q4 2012 The Saudi Arabia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical ...

• Pharmaceuticals - Global Outlook

  EURO€ 1,766.00USD$ 1,995.00GBP£ 1,177.00AUD$ 2,759.00JPY¥ 239,238.00SEK 15 694,00CHF 2'627.00CAD$ 2,559.00 Global Industry Analysts, Inc, Jan 2012 , Pages: 443
  for Prescription Pharmaceuticals by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2011 and ...

• Japan Pharmaceuticals and Healthcare Report Q4 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Aug 2011 , Pages: 109
  Japan Pharmaceuticals and Healthcare Report Q4 2011 Business Monitor International's Japan Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts ...

• Japan Pharmaceuticals and Healthcare Report Q1 2013

  EURO€ 891.00USD$ 1,160.00GBP£ 750.00AUD$ 1,134.00JPY¥ 114,506.00SEK 7 615,00CHF 1'093.00CAD$ 1,182.00 Business Monitor International, Dec 2012 , Pages: 99
  Japan Pharmaceuticals and Healthcare Report Q1 2013 BMI View: Japan's ageing and affluent population represents strong opportunities for foreign drugmakers. However, given its weak macroeconomic ...

• Life Science & Chemical Instrumentation Market (2011 – 2016) (Spectroscopy, Chromatography, Dna Sequencer & Amplifier, Lab Automation, Array, Flow Cytometer, Electrophoresis, Immuno Assay & Others) Global Trends, End User & Competitive Analysis

  EURO€ 3,574.00USD$ 4,650.00GBP£ 3,007.00AUD$ 4,548.00JPY¥ 459,108.00SEK 30 531,00CHF 4'383.00CAD$ 4,738.00 Markets and Markets, Feb 2012 , Pages: 391
  Sciences (U.S.), Shimadzu Corporation (Japan), Abbott Laboratories (U.S.), Hitachi High-technologies Corporation (Japan), and Siemens Healthcare Diagnostics (Germany). Scope of the repot The life science ...

• Japan Pharmaceuticals and Healthcare Report Q1 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Nov 2011 , Pages: 95
  Japan Pharmaceuticals and Healthcare Report Q1 2012 Japan Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations ...

• Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others

  EURO€ 2,690.00USD$ 3,500.00GBP£ 2,263.00AUD$ 3,423.00JPY¥ 345,565.00SEK 22 980,00CHF 3'299.00CAD$ 3,566.00 GlobalData, Jan 2013 , Pages: 122
  - Identify, understand and capitalize. 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 What is This Report About? 3 Drug Delivery Devices in Asia-Pacific 3.1 Drug Delivery ...

• Saudi Arabia Pharmaceuticals and Healthcare Report Q2 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Apr 2012 , Pages: 98
  Saudi Arabia Pharmaceuticals and Healthcare Report Q2 2012 Business Monitor International's Saudi Arabia Pharmaceuticals and Healthcare Report provides industry professionals and strategists ...

• Japan Pharmaceuticals and Healthcare Report Q2 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Feb 2012 , Pages: 94
  Japan Pharmaceuticals and Healthcare Report Q2 2012 Business Monitor International's Japan Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts ...

• Saudi Arabia Pharmaceuticals and Healthcare Report Q4 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Sep 2011 , Pages: 102
  Saudi Arabia Pharmaceuticals and Healthcare Report Q4 2011 Saudi Arabia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical ...

• Morocco Pharmaceuticals and Healthcare Report Q3 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Aug 2012 , Pages: 88
  Morocco Pharmaceuticals and Healthcare Report Q3 2012 The Morocco Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical ...

• Lebanon Pharmaceuticals and Healthcare Report Q3 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Jun 2011 , Pages: 82
  Lebanon Pharmaceuticals and Healthcare Report Q3 2011 The Lebanon Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical ...

• Cambodia Pharmaceuticals and Healthcare Report Q3 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Aug 2012 , Pages: 56
  Cambodia Pharmaceuticals and Healthcare Report Q3 2012 The Cambodia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical ...

• Antibacterials Market to 2017 - Innovative Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant Revenue Potential

  EURO€ 2,690.00USD$ 3,500.00GBP£ 2,263.00AUD$ 3,423.00JPY¥ 345,565.00SEK 22 980,00CHF 3'299.00CAD$ 3,566.00 GBI Research, May 2012 , Pages: 145
  Europe and Japan). This report offers a comprehensive insight into antibacterial market based on the seven indications covered. It provides a disease overview for each indication, market forecasting ...

• Belgium Pharmaceuticals and Healthcare Report Q2 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Mar 2012 , Pages: 84
  Belgium Pharmaceuticals and Healthcare Report Q2 2012 Belgium Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations ...

• Japan Pharmaceuticals and Healthcare Report Q3 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Jun 2011 , Pages: 106
  Japan Pharmaceuticals and Healthcare Report Q3 2011 The Japan Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations ...